Jane E. Honeyman
The University of Melbourne · 17 works · 1,574 citations · h-index 13
Top works
- Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity
- Thienopyridone Drugs Are Selective Activators of AMP-Activated Protein Kinase β1-Containing Complexes
- AMPK β1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin Resistance
- Whole Body Deletion of AMP-activated Protein Kinase β2 Reduces Muscle AMPK Activity and Exercise Capacity
- Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice
- Deletion of Skeletal Muscle SOCS3 Prevents Insulin Resistance in Obesity
- Liver-Specific Suppressor of Cytokine Signaling-3 Deletion in Mice Enhances Hepatic Insulin Sensitivity and Lipogenesis Resulting in Fatty Liver and Obesity
- Macrophage Deletion of SOCS1 Increases Sensitivity to LPS and Palmitic Acid and Results in Systemic Inflammation and Hepatic Insulin Resistance
- Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance
- Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation
- Effects of Estrogens on Adipokines and Glucose Homeostasis in Female Aromatase Knockout Mice
- Hepatic Glucose Intolerance Precedes Hepatic Steatosis in the Male Aromatase Knockout (ArKO) Mouse
- Sexual dimorphism in the glucose homeostasis phenotype of the Aromatase Knockout (ArKO) mice
- Antibody therapeutics – the evolving patent landscape